Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France
Noémie Roland, Bérangère Baricault, Alain Weill, Kim Bouillon, Rosemary Dray‐Spira, Lise Duranteau, Mahmoud Zureik
Abstract
This matched-cohort study uses data from the French National Health Insurance database to assess whether a 19.5-mg levonorgestrel intrauterine system, vs a 52-mg system, is associated with increased use of antidepressant, hypnotic, and anxiolytic medications.
Topics & Concepts
MedicineLevonorgestrelAnxiolyticAntidepressantCohortHypnoticCohort studyPsychiatryGynecologyPopulationFamily planningInternal medicineEnvironmental healthAnxietyResearch methodologyMaternal Mental Health During Pregnancy and PostpartumReproductive Health and ContraceptionPregnancy and Medication Impact